期刊文献+

胰腺实性-假乳头瘤临床病理特点及诊断 被引量:2

原文传递
导出
摘要 目的:研究胰腺实性-假乳头瘤临床病理特点、免疫表型及诊断。方法分析5例胰腺实性-假乳头瘤的组织病理学和免疫表型,结合文献进行分析。结果5例患者均为女性,大体肿瘤有包膜(2例)或边界较清,切面囊实性。瘤细胞大小形态较一致,无明显异型性;瘤细胞粘附性差,呈特征性假乳头结构及实体片状。免疫组化Viment、β-catenin阳性,CD99核旁点状阳性,AE1/AE3、CD10部分阳性,E-cadherin、CgA阴性,Ki-67阳性指数低;特染PAS嗜酸性小球阳性。结论胰腺实性-假乳头瘤具独特临床病理学特点,无特异性免疫表型,诊断需结合病理组织学特征和免疫组化综合分析。
出处 《中国实用医刊》 2015年第20期80-82,共3页 Chinese Journal of Practical Medicine
基金 国家自然基金项目(81273260)
  • 相关文献

参考文献7

  • 1Fred T. Bosman, F6tima Cameiro.崔全才,孟宇宏,等.译.消化系统肿瘤WHO分类(下册>[M].4版.北京:诊断病理学杂志社,2012:582-586.
  • 2Kawamoto S,Scudiere J,Hmban RH,et al. Solid-pseudopapillaryneo-plasm of the pancreas : spectrum of findings on muhidetector CT [ J ].Clin Imaging,2011,35 (1 ) :21-28.
  • 3马小龙,蒋慧,汪建华,陆建平,王莉,刘崎.囊型胰腺实性-假乳头状瘤的影像特征及与病理对照研究[J].中华放射学杂志,2012,46(12):1143-1145. 被引量:16
  • 4郭滟,费晓春,谢静,吴华成,金晓龙,肖家诚.胰腺实性假乳头肿瘤诊断及鉴别诊断标志物的筛选[J].诊断学理论与实践,2012,11(5):459-465. 被引量:5
  • 5Monirath H,Ahxandra DE,Potter LF,et al. Glypican-3 is a marker forsolid pseudopapillary neoplasm of the pancreas [ J]. Histopathology,2011,59(6) :1278-1279.
  • 6Bergmann F,Andrulis M,Hartwig W,et al. Discovered on gastrointes-tinal stromal tumor 1 ( DOG1) is expressed in pancreatic centroacinarcells and in solid-pseudopapifiary neoplasms-novel evidence for a his-togenetic relationship[ J]. Hum Pathol,2011,42(6) :817-823.
  • 7中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:291

二级参考文献20

  • 1Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 2Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 3Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 4Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 5Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 6Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 7Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 8Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 9Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.
  • 10Rindi G,Kl(o)ppel G,Alhman H,et al.TNM staging of foregut (neuro) endocrine tumors:a consensus proposal including a grading system.Virchows Arch,2006,449(4):395-401.

共引文献309

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部